caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1295793933

Samuel AltsteinD.O,

Family PracticeNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,559
Beneficiaries
—
Total drug cost
$270K
Distinct drugs
47
Brand share
20.8%
Top prescribed drugs
Atorvastatin Calcium199 claims
Amlodipine Besylate157 claims
Losartan Potassium131 claims
Rosuvastatin Calcium77 claims
Tamsulosin Hcl56 claims
REFERRAL NETWORK

Where Samuel Altstein's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BETH ISRAEL MEDICAL CENTER75382
Adam Persky
Emergency Medicine · New York, NY
1120
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BETH ISRAEL MEDICAL CENTER41194
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
1446
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
630
Unique beneficiaries
—
Total services
917
Distinct HCPCS
10
Medicare payment
$67K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,705 Family Practice providers in NY — above median (cohort median 473).